PROTAGONIST THERAPEUTICS INC (PTGX)

13F ownership of PROTAGONIST THERAPEUTICS INC among the superinvestors tracked on fructus.finance, based on their latest quarterly SEC filings.

Price history

Loading...
Tracked holders
4
Combined value
$6M
New buyers this quarter
3

Superinvestors holding PTGX

P
Polen Capital
Polen Capital Management LLC · Q2 2026
$3M
0.02% of portfolio
New buy
J
Joel Greenblatt
Gotham Asset Management, LLC · Q2 2026
$2M
0.01% of portfolio
New buy
R
Ray Dalio
Bridgewater Associates, LP · Q2 2026
$1M
0.00% of portfolio
New buy
S
Stanley Druckenmiller
Duquesne Family Office LLC · Q2 2026
$26K
0.49% of portfolio (+30.8%)
Added to

Based on 13F filings submitted to the SEC, published with roughly 45 days of lag. Only long equity positions are captured. See our guide on how to read a 13F filing for more context, or browse the full superinvestor consensus.